NCT00966290View on ClinicalTrials.gov

Anticoagulant Clinics and Vitamin K Antagonists

PHASE4CompletedINTERVENTIONAL
Enrollment

1,006

Participants

Timeline

Start Date

February 28, 2003

Primary Completion Date

December 31, 2006

Study Completion Date

December 31, 2006

Conditions
Blood Coagulation Disorders
Interventions
DRUG

Anticoagulant (warfarin, acenocoumarol, fluindione)

Anticoagulant clinic based shared-care group

DRUG

Anticoagulant (warfarin, acenocoumarol, fluindione)

Usual care group

Trial Locations (7)

29609

University Hospital, Brest

31000

Rangueil University Hospital, Toulouse

39100

Louis Pasteur Hospital, Dole

42055

Bellevue University Hospital, Saint-Etienne

59037

University Hospital, Lille

67091

University Hospital, Strasbourg

87042

Dupuytren University Hospital, Limoges

All Listed Sponsors
lead

University Hospital, Toulouse

OTHER

NCT00966290 - Anticoagulant Clinics and Vitamin K Antagonists | Biotech Hunter | Biotech Hunter